Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2005
06/15/2005EP1150973B1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
06/15/2005EP1126843A4 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme
06/15/2005EP1114031B1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
06/15/2005EP1104412B1 Tace inhibitors
06/15/2005EP1066059B1 Formulations for protection of peg-interferon alpha conjugates
06/15/2005EP1066050B1 Application of hsp70 proteins
06/15/2005EP1064277B1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
06/15/2005EP1062348B1 Recombinant onconase and fusion proteins of recombinant onconase
06/15/2005EP1001979B1 Cyclic azapeptides with angiogenic effect
06/15/2005EP0998556B1 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
06/15/2005EP0969866B1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
06/15/2005CN1628179A Gene and protein relating to hepatocellular carcinoma
06/15/2005CN1628167A Interleukin-2 gene transferred lymphokine activated killer cells
06/15/2005CN1628128A Mammal prolactin variants
06/15/2005CN1628117A Biocidal compounds and their preparation
06/15/2005CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion
06/15/2005CN1628103A Pyrimidine derivitive
06/15/2005CN1628101A 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
06/15/2005CN1628099A Water soluble phenylglycine derivatives
06/15/2005CN1627970A Safety shield system for prefilled syringe
06/15/2005CN1627962A Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts
06/15/2005CN1627961A Toluidine blue O drug substance and use thereof for in VIVO Staining and chemo therapeutic treatment of dysplastic tissues
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1626679A Methods for assessing and treating cancer
06/15/2005CN1626554A Interfusion protein between human serum albumin and interleukin, and encoding genes
06/15/2005CN1626552A Angiogenesis related molecules
06/15/2005CN1626549A Carbowax alcoholized ramification of TimopEntin, combination of medication and application
06/15/2005CN1626545A Compound extracted from hull and stem of yellow horn, extracting method and application
06/15/2005CN1626516A Novel intermediate for prepn. of pyrazolopyrimidinones
06/15/2005CN1626514A Method for preparing-4-bromine-7-methyl isatin
06/15/2005CN1626507A Compound of antitumor antibiotic of new carbon framework as well as preparation method and application
06/15/2005CN1626240A Antigen-specific lgE antibody production inhibitors
06/15/2005CN1626229A Method for preparing secret recipe having peculiar curative effect for treating tumor
06/15/2005CN1626228A Extractive from decoction of rehmannia including six elements, combination of medication, and medical use
06/15/2005CN1626225A Antineoplastic combination of medication
06/15/2005CN1626207A Preparation including unique ingredient and fabricating method
06/15/2005CN1626199A Powder injection preparation for generating channels and vessels, and preparation method
06/15/2005CN1626175A Big bitter gourd in application for preparing medication
06/15/2005CN1626174A Combination of medication for treating tumorous diseases and preparation method
06/15/2005CN1626171A Chinese traditional medicine for external application for treating primary liver cancer and cirrhosis of liver
06/15/2005CN1626168A Leadwort (white snowflake) preparation
06/15/2005CN1626158A Method for preparing liquid for strengthening the body resistance and reducing the stagnation
06/15/2005CN1626156A Method for preparing liquid for raising white blood cell
06/15/2005CN1626109A Substance of poly pentenol capsule and its prepn. method
06/15/2005CN1626105A Nano emulsion of containing ginsenoside, preparation method and usage
06/15/2005CN1626104A Nano emulsion of containing ginsenoside, preparation method and usage
06/15/2005CN1626102A Nano emulsion of containing ginsenoside, preparation method and usage
06/15/2005CN1626101A Nano emulsion of containing ginsenoside, preparation method and usage
06/15/2005CN1626100A Injection of liposome of daunorubicin or hydrochloric daunorubicin and preparationmethod
06/15/2005CN1626095A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
06/15/2005CN1626088A Hydrolase inhibitor of adenosine homeotypic cysteamine acid and usage
06/15/2005CN1626087A New usage of STI-571 in application for treating acute leukaemia in marrow type
06/15/2005CN1626082A Nano particles of polyglycol-poly(lactide-caprolactone) of carrying camptothecin and preparation method
06/15/2005CN1626068A Combination of medication in use for improving dissolution of curcumin and bioavailability as well as preparation method
06/15/2005CN1625964A Capsule of natural protein containing selenium and American ginseng
06/15/2005CN1625963A Capsule of natural protein containing selenium and root of pilose asiabell
06/15/2005CN1206244C Extractive in Taxus chinensis branches and leaves and extracting method thereof
06/15/2005CN1206242C Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide
06/15/2005CN1206230C 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
06/15/2005CN1206228C N-heterocyclic derivatives as NOS inhibitors
06/15/2005CN1206219C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/15/2005CN1206213C N-arylsulfonyl amino acid omega amides
06/15/2005CN1205999C Liposone composition and method for administration of a radiosensitizer
06/15/2005CN1205998C Antigen-specific IgE antibody production inhibitors
06/15/2005CN1205996C Mannan peptide freeze dried pwoder ampoule for injection
06/15/2005CN1205993C Huaaidan pellet medicine for treating cancer and preparation method thereof
06/15/2005CN1205967C Chinese medicine pill for treating cancer and viral hepatitis and producing process thereof
06/15/2005CN1205963C Medicine for treating oophoritic cyst and its preparation process
06/15/2005CN1205960C Auxiliary medicine for treating esophagus cancer and processing method thereof
06/15/2005CN1205953C Medicinal composition for treating cancer
06/15/2005CN1205949C Externally applied ointment for treating prostatosis and its prepn
06/15/2005CN1205937C Phosphatidic acid-comprising compositions
06/15/2005CN1205931C Pharmaeutical agent comprising benzamide derivative as active ingredient
06/15/2005CN1205923C Liposome-entrapped topoisomerase inhibitors
06/14/2005US6906203 Anticancer agents; such as 2-Amino-3-cyano-4-(2-bromo-4,5-dimethoxyphenyl)-4H-indolo(4,5-b)pyran
06/14/2005US6906199 Process for preparing distamycin derivatives
06/14/2005US6906182 Inhibiting abnormal cellular proliferation in a mammal; and a method of inhibiting replication of a virus in a mammal.
06/14/2005US6906175 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor.
06/14/2005US6906174 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
06/14/2005US6906105 Administering to a cancer patient an effective amount of chalcone or its derivaties to treat the tumor/cancer
06/14/2005US6906103 Compounds possessing antibacterial, antifungal or antitumor activity
06/14/2005US6906101 Taxane derivatives and processes for the preparation thereof
06/14/2005US6906100 Optionally esterified 5-ethylidene-4-carboxy-2-pyranones as a cytoprotective agent
06/14/2005US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase
06/14/2005US6906091 Inhibiting metastasis with a 2-(alkoxycarbonylamino)benzimidazole prodrug
06/14/2005US6906088 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent
06/14/2005US6906082 Cholesteryl ester transfer protein inhibitor; anticholesterol agents, cardiovascular disorders; synergistic mixture
06/14/2005US6906080 Antiinflammatory agents, analgesics, drug abuse, alcoholism
06/14/2005US6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
06/14/2005US6906059 Administering cardioprotective amount of a benzazepin-N-acetic acid derivative for inhibiting or treating heart damage induced by a cardiotoxic medicamet in a mammal
06/14/2005US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents
06/14/2005US6906051 Viricides, fungicides, microbiocides, osteoporosis
06/14/2005US6906048 N-acetylcolchinol-O-phosphate combination therapies with vascular damaging activity
06/14/2005US6906040 Method for reducing toxicity of combined chemotherapies
06/14/2005US6905874 Contacting T-cells with a surface that has attached thereto one or more agents that ligate a cell surface moiety and applying a force that drives cell concentration and cell surface moiety ligation
06/14/2005US6905855 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
06/14/2005US6905844 Human cervical cancer 2 protooncogene and protein encoded therein
06/14/2005US6905832 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (APP)
06/14/2005US6905820 Polyamide nucleic acid derivatives, and agents and processes for preparing them
06/14/2005US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases
1 ... 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 ... 2211